A Clinical Trial Investigating the Effect of Salmon Bone Meal on Bone Mass Among Osteopenic Women
← catalyst calendarSponsored by Hofseth Biocare ASA (industry) · HBC.OL — their whole pipeline →. With Møre og Romsdal Hospital Trust.
Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Randomized · Triple · Prevention
Enrollment
80actual
Sites
3
Country
Norway
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2021-09-22 | actual | When the study began enrolling |
| Primary completion | 2025-06-12 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-06-12 | actual | The whole study's end, after follow-up |
| First posted | 2021-10-04 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-09-23 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Osteopenia
- Osteopenia of the Elderly
Interventions
- Dietary supplement: CalGo
- Other: Placebo
Primary outcome
what the primary-completion date above is the date OFMean change in Bone Mass Density (BMD) of the femoral neck at Month 12, and Month 24.
measured Baseline, 12 Months, and 24 Months.
Permalink · HBC.OL's whole pipeline · Catalyst calendar · Every registered study · What changed